1. Home
  2. INDP vs IPDN Comparison

INDP vs IPDN Comparison

Compare INDP & IPDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • IPDN
  • Stock Information
  • Founded
  • INDP 2000
  • IPDN 2003
  • Country
  • INDP United States
  • IPDN United States
  • Employees
  • INDP N/A
  • IPDN N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • IPDN EDP Services
  • Sector
  • INDP Health Care
  • IPDN Technology
  • Exchange
  • INDP Nasdaq
  • IPDN Nasdaq
  • Market Cap
  • INDP 6.0M
  • IPDN 5.4M
  • IPO Year
  • INDP N/A
  • IPDN 2013
  • Fundamental
  • Price
  • INDP $7.30
  • IPDN $1.83
  • Analyst Decision
  • INDP Strong Buy
  • IPDN
  • Analyst Count
  • INDP 2
  • IPDN 0
  • Target Price
  • INDP $238.00
  • IPDN N/A
  • AVG Volume (30 Days)
  • INDP 24.5K
  • IPDN 376.7K
  • Earning Date
  • INDP 08-11-2025
  • IPDN 08-12-2025
  • Dividend Yield
  • INDP N/A
  • IPDN N/A
  • EPS Growth
  • INDP N/A
  • IPDN N/A
  • EPS
  • INDP N/A
  • IPDN N/A
  • Revenue
  • INDP N/A
  • IPDN $6,508,349.00
  • Revenue This Year
  • INDP N/A
  • IPDN N/A
  • Revenue Next Year
  • INDP N/A
  • IPDN N/A
  • P/E Ratio
  • INDP N/A
  • IPDN N/A
  • Revenue Growth
  • INDP N/A
  • IPDN N/A
  • 52 Week Low
  • INDP $7.30
  • IPDN $0.97
  • 52 Week High
  • INDP $59.36
  • IPDN $11.20
  • Technical
  • Relative Strength Index (RSI)
  • INDP 31.62
  • IPDN 39.57
  • Support Level
  • INDP $8.00
  • IPDN $2.42
  • Resistance Level
  • INDP $10.57
  • IPDN $3.06
  • Average True Range (ATR)
  • INDP 0.79
  • IPDN 0.24
  • MACD
  • INDP -0.43
  • IPDN -0.12
  • Stochastic Oscillator
  • INDP 0.00
  • IPDN 4.65

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About IPDN Professional Diversity Network Inc.

Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates majority of its revenue from TalentAlly Network Segment.

Share on Social Networks: